Business · 26/10/2016Updated: 10/17/2026 · 1 min read

FDA Announces Draft Guidance for Developing Drugs to Treat Low Sexual Interest in Women

The FDA is releasing a draft guidance to help pharmaceutical companies develop treatments for low sexual interest, desire, and/or arousal in women, with a focus on phase 3 clinical trials.